The Ponce de Leon Center (Ponce) Clinical Research Site (CRS) conducts HIV/AIDS Clinical Trials among HIV-infected and at-risk adolescents and adults.
- In 1996, the Ponce CRS began conducting studies as part of the NIH-funded AIDS Clinical Trials Group (ACTG). Since then, more than 500 patients with HIV have participated in ACTG studies conducted at the Ponce CRS. To learn more about ACTG studies, please visit the ACTG website.
- In 2009, the Ponce CRS began conducting studies as part of the NIH-funded HIV Prevention Trials Network (HPTN). Since then, more than 400 individuals at risk for HIV have participated in HPTN studies conducted at the Ponce CRS. To learn more HPTN studies, please visit the HPTN website.
- In 2013, the Ponce CRS became one of the four clinical research sites that form the Emory-CDC HIV/AIDS Clinical Trials Unit (CTU); this CTU is a collaboration between Emory and the Centers for Disease Control and Prevention (CDC) and is funded by the Division of AIDS of the National Institute of Health. To learn more, please visit our CTU website.
In addition to being one of the four clinical research sites of the Emory-CDC HIV/AIDS Clinical Trials Unit, the Ponce CRS is part of the Ponce De Leon Center which is an HIV care clinic within the Grady Health System that serves diverse and underrepresented minority populations. Lastly, the Ponce CRS is part of the Emory Center for AIDS Research (CFAR) Clinical Research Core, a research group within Emory University that conducts NIH-funded HIV/AIDS research.